Literature DB >> 28631027

Validation of a Liver Index and Its Significance for HCC Aggressiveness.

Brian I Carr1, Vito Guerra2.   

Abstract

BACKGROUND: We recently constructed a liver index (LI) from four liver parameters, namely: blood total bilirubin, gamma glutamyl transpeptidase (GGTP), albumin, and platelet levels (a cirrhosis surrogate). We found that the scores for the liver index related significantly to a four-parameter HCC aggressiveness index (maximum tumor diameter, multifocality, percent portal vein invasion, and blood AFP levels). AIMS: To validate the relationship of liver parameters to tumor aggressiveness parameters in a larger, different HCC dataset.
RESULTS: We now confirm these associations in another large HCC cohort. Furthermore, this liver index showed significant trends with the individual HCC aggressiveness parameters.
CONCLUSIONS: These results provide further support for the idea that liver microenvironment, as reflected in liver function tests, may relate to HCC behavior.

Entities:  

Keywords:  Aggressiveness index; HCC parameters; Liver function

Year:  2017        PMID: 28631027     DOI: 10.1007/s12029-017-9971-4

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  19 in total

1.  Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo.

Authors:  M H Hanigan; B C Gallagher; D M Townsend; V Gabarra
Journal:  Carcinogenesis       Date:  1999-04       Impact factor: 4.944

2.  Platelet-related phenotypic patterns in hepatocellular carcinoma patients.

Authors:  Brian I Carr; Chih-Yun Lin; Sheng-Nan Lu
Journal:  Semin Oncol       Date:  2014-04-23       Impact factor: 4.929

3.  Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.

Authors:  Sheng-Nan Lu; Jing-Houng Wang; Shiann-Long Liu; Chao-Hung Hung; Chien-Hung Chen; Hung-Da Tung; Tsung-Ming Chen; Wu-Shiung Huang; Chuan-Mo Lee; Chia-Cheng Chen; Chi-Sin Changchien
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

4.  Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.

Authors:  Khairuddin Memon; Laura M Kulik; Robert J Lewandowski; Edward Wang; Jonathan Wang; Robert K Ryu; Ryan Hickey; Michael Vouche; Talia Baker; Daniel Ganger; Vanessa L Gates; Ali Habib; Mary F Mulcahy; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2014-03-07       Impact factor: 3.464

5.  Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani
Journal:  Semin Oncol       Date:  2014-03-06       Impact factor: 4.929

Review 6.  Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.

Authors:  Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

7.  A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.

Authors:  Brian I Carr; Vito Guerra
Journal:  Oncology       Date:  2016-03-15       Impact factor: 2.935

Review 8.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

9.  A Liver Index and its Relationship to Indices of HCC Aggressiveness.

Authors:  Brian I Carr; Vito Guerra; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Alberto Masotto; Franco Trevisani
Journal:  J Integr Oncol       Date:  2016-09-05

10.  Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle.

Authors:  Shunsuke Nojiri; Takashi Joh
Journal:  Int J Mol Sci       Date:  2014-03-24       Impact factor: 5.923

View more
  3 in total

1.  Microscopic Portal Vein Invasion in Relation to Tumor Focality and Dimension in Patients with Hepatocellular Carcinoma.

Authors:  Brian I Carr; Vito Guerra; Rossella Donghia; Volkan Ince; Sami Akbulut; Veysel Ersan; Sertac Usta; Burak Isik; Emine Samdanci; Sezai Yilmaz
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

2.  Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma.

Authors:  Xiao Fu; Yixuan Yang; Dazhi Zhang
Journal:  Liver Int       Date:  2021-12-07       Impact factor: 8.754

3.  Circular RNA hsa_circ_0004277 Stimulates Malignant Phenotype of Hepatocellular Carcinoma and Epithelial-Mesenchymal Transition of Peripheral Cells.

Authors:  Chuanrong Zhu; Yang Su; Lei Liu; Shaochuang Wang; Yuting Liu; Jinsheng Wu
Journal:  Front Cell Dev Biol       Date:  2021-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.